NCT03233724 2023-05-31Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasNational Institutes of Health Clinical Center (CC)Phase 1/2 Terminated9 enrolled 14 charts
NCT00978250 2019-12-27A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)National Institutes of Health Clinical Center (CC)Phase 2 Completed95 enrolled 15 charts